...
首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >Myocardial perfusion imaging: a plus for coronary risk classification in diabetics.
【24h】

Myocardial perfusion imaging: a plus for coronary risk classification in diabetics.

机译:心肌灌注显像:对糖尿病患者进行冠脉危险性分类的加分项。

获取原文
获取原文并翻译 | 示例
           

摘要

Type 2 diabetes mellitus is the most common form of diabetes worldwide (>90%). Long-term complications of diabetes include microvascular and macrovascular damage. Life expectancy of patients with diabetes remains substantially shorter than that of individuals without diabetes, mainly because of coronary heart disease (CHD) [1]. However, CHD risk in patients with diabetes is highly variable and difficult to stratify by conventional clinical markers [2, 3]. Moreover, the early identification of CHD in diabetics is difficult due to its often silent or atypical presentation in this population. As a result, CHD in diabetics may be diagnosed several years after its onset, when the disease is in an advanced stage, frequently in the form of myocardial infarction (MI) or sudden cardiac death. To improve outcomes, common CHD risk factors should be assessed at least annually, along with the presence of micro- or macroalbuminuria, and be actively managed [4, 5].
机译:2型糖尿病是全世界最常见的糖尿病形式(> 90%)。糖尿病的长期并发症包括微血管和大血管损害。糖尿病患者的预期寿命仍然比非糖尿病患者的预期寿命短得多,这主要是由于冠心病(CHD)[1]。但是,糖尿病患者的冠心病风险变化很大,并且难以通过常规临床标志物进行分层[2,3]。此外,由于在该人群中常常无声或非典型表现,因此很难在糖尿病中及早发现CHD。结果,糖尿病患者的冠心病可在其发病数年后(即疾病处于晚期)被诊断出,通常以心肌梗塞(MI)或心源性猝死的形式出现。为了改善结局,应至少每年评估常见的冠心病危险因素,以及是否存在微量或大量白蛋白尿,并进行积极管理[4,5]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号